The aldehyde dehydrogenase enzymes are likely to protect stem cells by detoxification of cell toxic compounds, which indicates that ALDH1 might prevent prostate cancer stem cells from conventional chemotherapy attack, while effective inhibition of ALDH1 could enhance the chemotherapy efficiency. This evidence concerns the gene ALDH1A1 and prostate cancer.